allergies

Rapt pays $35M for challenger to Novartis, Roche drug

Rapt Therapeutics has charted a new course following the implosion of its lead program, agreeing to pay $35 million for a long-acting rival to Xolair.

Nick Paul Taylor Dec 23, 2024 8:10am

Holoclara wriggles into ph. 1, sets sights on immune disease

Dec 18, 2024 9:05am

Food allergy biotech DBV is running out of cash

Mar 8, 2024 10:30am

Getty Image picture of peanut butter and nuts to show allergy

Could Dupixent find a new life targeting 'memory' B cells?

Feb 9, 2024 11:50am

Photo of a left turn sign on a hilly road headed downhill

Altamira lays off 25% of staff weeks after allergy spray spinoff

Dec 11, 2023 9:58am

Alladapt's 15-allergen drug desensitizes kids to multiple foods

Jun 13, 2023 8:15am